CASE REPORT ON DOCETAXEL-INDUCED INTERSTITIAL LUNG DISEASE
Docetaxel belongs to taxane family of antineoplastic agents that are indicated for the treatment of locally advanced or metastatic non-small-cell lung cancer. Docetaxel is associated with many adverse effects, and pulmonary reaction has an incidence of 41%. However, interstitial pulmonary disease...
Gespeichert in:
| Veröffentlicht in: | Asian journal of pharmaceutical and clinical research 2017-10, Vol.10 (10), p.10 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Docetaxel belongs to taxane family of antineoplastic agents that are indicated for the treatment of locally advanced or metastatic non-small-cell lung cancer. Docetaxel is associated with many adverse effects, and pulmonary reaction has an incidence of 41%. However, interstitial pulmonary disease is found to occur only in |
|---|---|
| ISSN: | 0974-2441 0974-2441 |
| DOI: | 10.22159/ajpcr.2017.v10i10.19043 |